ɬÀï·¬

ASBMB Annual Meeting

Branon works to break barriers in science and higher education

Joseph Ong
By Joseph Ong
March 3, 2021

When Tess Branon arrived at the Massachusetts Institute of Technology for grad school, she felt out of place in a class full of Harvard and Yale graduates. However, as Branon, a North Carolina native and graduate of Western Carolina University, progressed through her classes and research, she realized that her undergraduate education fully had prepared her to excel.

Branon-Tess-445x435.jpg
Tess Branon

"Academia is a very exclusive institution," she said. "You have to go down a path with, yes, merit and intelligence, but also several factors that are out of your control, like where you are born or what opportunities are available to you."

In the middle of Branon's Ph.D., her , moved cross-country from MIT to Stanford. Moving to California was a difficult decision for Branon, but after finishing her Ph.D., she ended up staying in the Bay Area. Now, she's a postdoc in Greg Barton's lab at the University of California, Berkeley, studying host–microbiome interactions and how gut bacteria affect physiology and disease.

Changing from bioengineering to microbiome studies was a challenge, Branon said, and learning mouse work and immunology has been demanding but rewarding. Thinking about proximity labeling techniques from an engineering perspective was important during her Ph.D., but for her postdoc she sought to answer biological questions and understand how organisms interact to influence each other's biology at a molecular level, she said. "In my work, I want to make the quality of human life better."

After her MIT experience, Branon became passionate about mentoring the next generation of scientists and addressing equity issues in higher education. She hopes eventually to lead her own research group and dismantle barriers in academia.

At UC Berkeley, as a member of the Union for Postdocs and Academic Researchers, Branon is pushing for restructuring of academic institutions, with particular focus on community outreach, resolving racial biases, and creating more diverse and inclusive academic environments.

"Even in progressive California," she said, "diversity and equity issues are still definitely a problem."

Fast, nontoxic proximity labeling with TurboID

As a grad student, Tess Branon used directed evolution to engineer a new enzyme that addressed the shortcomings of previous proximity labeling methods. She worked on to identify interacting proteins of interest.

"In multicellular organisms, old proximity labeling methods are inefficient, require toxic labeling conditions (so they can't be used in animals), or give insufficient labeling," she said.

TurboID can label cellular substrates efficiently in just 10 minutes and uses biotin, a nontoxic compound, as a chemical label. Branon and her collaborators at Stanford and Harvard used TurboID labeling in worms and flies, demonstrating its safety and efficacy in whole animals. Later experiments verified that it can be used in and .

Branon thinks the next step for proximity labeling is to study the interactors of an endogenous protein of interest without any labeling enzyme tags that might disturb the protein's natural function.

"Finding a method where we can map the interactome, where we don't have to fuse APEX or TurboID" to the protein of interest, she said, "would be really useful."

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Joseph Ong
Joseph Ong

Joseph Ong is a Ph.D. student in biochemistry and molecular biology at the University of California, Los Angeles.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.